Jerry Wan's most recent trade in Achieve Life Sciences Inc. was a trade of 48,000 Performance Restricted Stock Unit (PRSU) done . Disclosure was reported to the exchange on Jan. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 48,000 | 48,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 3.67 per share. | 16 Aug 2024 | 2,857 | 12,664 (0%) | 0% | 3.7 | 10,485 | Common Stock |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 5,625 | 0 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 5,625 | 12,057 (0%) | 0% | 0 | Common Stock | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.51 per share. | 19 Apr 2024 | 2,250 | 9,807 (0%) | 0% | 4.5 | 10,148 | Common Stock |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 24,500 | 24,500 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Wan Jerry | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 1,250 | 0 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 1,250 | 7,101 (0%) | 0% | 0 | Common Stock | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.29 per share. | 28 Apr 2023 | 669 | 6,432 (0%) | 0% | 8.3 | 5,546 | Common Stock |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 5,625 | 8,861 (0%) | 0% | 0 | Common Stock | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 5,625 | 5,625 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.80 per share. | 21 Apr 2023 | 3,010 | 5,851 (0%) | 0% | 6.8 | 20,468 | Common Stock |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 15,000 | 15,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 4.37 per share. | 16 Aug 2022 | 2,827 | 3,502 (0%) | 0% | 4.4 | 12,354 | Common Stock |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.37 per share. | 16 Aug 2022 | 266 | 3,236 (0%) | 0% | 4.4 | 1,162 | Common Stock |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 1,250 | 1,344 (0%) | 0% | 0 | Common Stock | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 1,250 | 1,250 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.43 per share. | 28 Apr 2022 | 669 | 675 (0%) | 0% | 7.4 | 4,971 | Common Stock |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 11,250 | 11,250 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 11,250 | 11,250 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 11 | 100 (0%) | 0% | 0 | Common Stock | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 11 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.83 per share. | 17 Aug 2021 | 6 | 94 (0%) | 0% | 6.8 | 41 | Common Stock |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 2,500 | 2,500 | - | - | Performance Restricted Stock Unit (PRSU) |